Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma

Clinical trial NCT00653328 · TERMINATED

Trial details

NCT number: NCT00653328
Sponsor: Vanderbilt-Ingram Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Fallopian Tube Cancer Ovarian Cancer Peritoneal Cavity Cancer

Start date: 2003-05-01
Primary completion: 2009-03-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.